Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
14.84 Down 0.35(2.30%) Jul 11, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 10,000   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit 10,000   -   -   -  
Operating Expenses
Research Development15,555  8,863  10,351  6,934  
Selling General and Administrative8,096  8,876  5,381  4,520  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,651) (17,739) (15,732) (11,454)
Income from Continuing Operations
Total Other Income/Expenses Net121  71  81  96  
Earnings Before Interest And Taxes(13,530)(17,668)(15,651)(11,358)
Interest Expense -   -   -   -  
Income Before Tax(13,530)(17,668)(15,651)(11,358)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(13,530)(17,668)(15,651)(11,358)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,530) (17,668) (15,651) (11,358)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (13,530) (17,668) (15,651) (11,358)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.